FibroBiologics FBLG
NASDAQ FBLG
$1.02 +0.02 (+2.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

FibroBiologics (FBLG) Other Non-Current Liabilities (2022 - 2024)

Updated

FibroBiologics' Other Non-Current Liabilities came in at $2.89 million for Q3 2024, down 40.0% from the prior quarter.

Analysis

FibroBiologics (FBLG) Other Non-Current Liabilities (2022 - 2024) Analysis & Trends

At the end of FY2023, FibroBiologics' Other Non-Current Liabilities was $2,573, down 99.9% from FY2022.

  • Going back by year, Other Non-Current Liabilities was $2.57 million in FY2022.
  • The five-year range for quarterly Other Non-Current Liabilities is $2,573 (Q4 2023) to $4.81 million (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 FibroBiologics 6.40 Mn -8.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 2.89 Mn
Jun 30, 2024 4.81 Mn
Dec 31, 2023 2,573.00
Jun 30, 2023 2.57 Mn
Mar 31, 2023 463,000.00
Dec 31, 2022 2.57 Mn
API Access

FibroBiologics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=FBLG&period=max&api_key=YOUR_API_KEY